Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

CRNXCRNX
24 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in CRINETICS PHARMACEUTICALS IN

BAKER BROS. ADVISORS LP holds 2.4M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $88M as of 2026-Q2. CRNX represents 0.4% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$88M

Current Shares

2.4M

Total Value Change

+$85M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
2.4M
0.0%
$88M0.4%$37.42
0
2026-Q1
Increased
2.4M
+42.6%
$85.4M0.5%$36.32
48
2025-Q4
Increased
1.6M
+488.9%
$76.8M0.4%$46.55
57
2025-Q3
Unchanged
280,000
0.0%
$11.7M0.1%$41.65
0
2025-Q2
New
280,000
-
$8.1M0.1%$28.76
38
2024-Q4
Exited
0
-100.0%
$00.0%$51.13
0
2024-Q3
Unchanged
103,927
0.0%
$5.3M0.1%$51.10
0
2024-Q2
New
103,927
-
$4.7M0.1%$44.79
37
2022-Q4
Exited
0
-100.0%
$00.0%$18.30
0
2022-Q3
Decreased
735,716
-11.1%
$14.4M0.1%$19.64
0
2022-Q2
Unchanged
827,480
0.0%
$15.4M0.1%$18.65
0
2022-Q1
Unchanged
827,480
0.0%
$18.2M0.1%$21.95
0
2021-Q4
Decreased
827,480
-10.1%
$23.5M0.1%$28.41
0
2021-Q3
Unchanged
920,656
0.0%
$19.4M0.1%$21.05
0
2021-Q2
Increased
920,656
+49.3%
$17.4M0.1%$18.85
39
2021-Q1
Unchanged
616,520
0.0%
$9.4M0.0%$15.28
0
2020-Q4
Increased
616,520
+103.9%
$8.7M0.0%$14.11
44
2020-Q3
Decreased
302,320
-4.9%
$4.7M0.0%$15.67
0
2020-Q2
Increased
317,857
+81.6%
$5.6M0.0%$17.52
42
2020-Q1
Unchanged
175,000
0.0%
$2.6M0.0%$14.70
0
2019-Q4
Unchanged
175,000
0.0%
$4.4M0.0%$25.09
0
2019-Q3
Increased
175,000
+31.6%
$2.6M0.0%$15.04
33
2019-Q2
Increased
132,985
+1.3%
$3.3M0.0%$25.00
27
2019-Q1
New
131,250
-
$3M0.0%$22.76
36

Other major holders of CRNX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used